AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Dailyglim M 3mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Leeford Healthcare Ltd

Salt Composition

Glimepiride (3mg) + Metformin (500mg)

Overview Dailyglim M 3mg/500mg Tablet SR

Metformin/Glimepiride 3mg/500mg extended-release tablets are classified as antidiabetic medications. This combination therapy treats type 2 diabetes in adults by managing blood glucose levels. Administer this medication with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical guidance can lead to elevated blood sugar, increasing the risk of kidney complications, vision loss, neuropathy, and limb amputation. This medication is only one component of a comprehensive diabetes management plan, requiring adherence to a healthy diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is a frequent side effect. Learn to recognize symptoms like sweating, dizziness, headache, and tremors, and know how to treat them promptly. Maintain regular mealtimes and carry a readily available source of glucose, such as sugary snacks or juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is possible. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Inform your physician of any history of heart disease before commencing treatment; it may be unsuitable. Pregnant or lactating women should seek medical advice before use. Regular blood sugar monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.

Uses of Dailyglim M 3mg/500mg Tablet SR

Managing Type 2 Diabetes

Major Benefits of Dailyglim M 3mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. It's recommended to take Dailyglim M 3mg/500mg Sustained-Release Tablet with meals.

Common Side effects of Dailyglim M 3mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Dailyglim M 3mg/500mg Tablet SR:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet; avoid chewing, crushing, or fracturing it. Dailyglim M 3mg/500mg Extended-Release tablets should be taken with meals.

How Dailyglim M 3mg/500mg Tablet SR works:

Each Dailyglim M 3mg/500mg sustained-release tablet combines glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thus reducing blood glucose. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose uptake, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent alcohol use with Dailyglim M 3mg/500mg SR tablets is contraindicated.

PregnancyPregnancyCONSULT YOUR DOCTOR

The extended-release Dailyglim M 3mg/500mg tablet may pose risks during pregnancy. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential advantages against any hazards prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Prolonged-release Dailyglim M 3mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity associated with this medication.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

Patients with kidney impairment should exercise caution when using Dailyglim M 3mg/500mg SR tablets, potentially requiring dosage modification. Consult your physician for guidance. Dailyglim M 3mg/500mg SR tablets are contraindicated in patients with severe kidney disease. Regular monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Individuals with liver impairment should use Dailyglim M 3mg/500mg SR tablets cautiously. Dosage modifications for Dailyglim M 3mg/500mg SR tablets may be necessary. Physician consultation is advised. A reduced initial dose of Dailyglim M 3mg/500mg SR tablets is typically prescribed for patients with mild to moderate liver disease; however, it's contraindicated in those with severe hepatic dysfunction.

What if you forget to take Dailyglim M 3mg/500mg Tablet SR :

Should you forget to take your Dailyglim M 3mg/500mg SR tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Dailyglim M 3mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Dailyglim M 3mg/500mg Tablet SR

Store this medication in its original, tightly closed container, as directed on the label. Discard any unused medication and ensure it's kept out of reach of children, pets, and others.
Dailyglim M 3mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excess blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, discontinue Dailyglim M 3mg/500mg Tablet SR and seek immediate medical attention.
Dailyglim M 3mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This medication improves blood glucose control when used with a healthy diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It is not suitable for type 1 diabetes.
Dailyglim M 3mg/500mg SR tablets may cause common side effects such as low blood sugar, taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Dailyglim M 3mg/500mg Tablet SR can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in extremities, weakness, urinary problems, cognitive changes, and ataxia. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Dailyglim M 3mg/500mg SR tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Dailyglim M 3mg/500mg SR tablets with alcohol is unsafe. Alcohol can exacerbate the drug's effect, potentially causing dangerously low blood sugar (hypoglycemia) and increasing the risk of lactic acidosis.
Dailyglim M 3mg/500mg Tab...
53
MRP 65
18% off